Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of the phytocannabinoid cannabidivarin (CBDV) in the treatment of epilepsy

Use of the phytocannabinoid cannabidivarin (CBDV) in the treatment of epilepsy

US Patent 10799467 · Granted Oct 13, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Use of the phytocannabinoid cannabidiol (CBD) in combination with a standard ant2025
Use of the phytocannabinoid cannabidiol (CBD) in combination with a standard ant2025
Use of cannabidiol in the treatment of tuberous sclerosis complex2025
Pharmaceutical composition comprising the phytocannabinoids cannabidivarin (CBDV2024
Pharmaceutical composition comprising the phytocannabinoids cannabidivarin (CBDV2024
Use of the phytocannabinoid cannabidivarin (CBDV) in the treatment of epilepsy2024
Use of the phytocannabinoid cannabidivarin (CBDV) in the treatment of epilepsy2024
Use of the phytocannabinoid cannabidivarin (CBDV) in the treatment of epilepsy2024
Use of the phytocannabinoid cannabidivarin (CBDV) in the treatment of epilepsy2024
7-OH-cannabidiol (7-OH-CBD) and/or 7-OH-cannabidivarin (7-OH-CBDV) for use in th2023
7-OH-cannabidiol (7-OH-CBD) and/or 7-OH-cannabidivarin (7-OH-CBDV) for use in th2023
Pharmaceutical composition comprising the phytocannabinoids cannabidivarin (CBDV2022